BioSpace News Archive

NantKwest Inc. (Nasdaq:NK), a leading, clinical-stage, natural killer cell based therapeutics company, today announced the launch of a novel triple combination, phase II clinical trial in Merkel cell carcinoma (MCC).

Liht Cannabis Corp. (or the “Company”) (CSE: LIHT) (OTCQX: LIHTF) is pleased to advise on construction progress of the first two, of ten, facilities in Celista, British Columbia.

Senolytic Therapeutics, an innovator in senescent cell research and one of the first Daughter companies to join the hub-and-spoke business model of Life Biosciences, is being recognized by leading institutions for its work to combat aging and age-related decline.

ClearHealth Quality InstituteTM (CHQI), an independent health care accrediting body, is pleased to announce its new Online Parity Compliance Tool, the first and only comprehensive digital resource designed for health plans and other organizations to build, implement, and manage a parity compliance program that meets key regulatory and accreditation requirements.

According to the Texas Mesothelioma Victims Center, “We want to make certain a public utility or power plant worker with recently diagnosed mesothelioma anywhere in Texas receives the very best possible financial compensation settlement results.

Debbie’s Dream Foundation: Curing Stomach Cancer (DDF) is excited to announce its 10th Annual Night of Laughter which will take place on Sunday, January 27, 2019, at Stage 954 at The Casino @ Dania Beach.

SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene & cell therapy, announced today that it signed a license and collaboration agreement with Denali Therapeutics (NASDAQ: DNLI),

NanoSphere Health Sciences, Inc. (CSE:NSHS) (OTC:NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, today announced the launch of its new, DoseCode-enabled Evolve Formulas products in the Colorado market, leveraging industry-first technology from Denver-based healthcare startup Gofire.

Complete fourth quarter and full year 2018 financial results will be announced on Tuesday, February 26, 2019

The Mesothelioma Compensation Center says, “We are the top branded source in the nation when it comes to financial compensation for an oil refinery worker who has confirmed mesothelioma or asbestos exposure lung cancer.